The US Long Acting Analgesic Market: Size, Trends & Forecasts (2017-2021) November 2017
The US Long Acting Analgesic Market: Coverage Executive Summary and Scope Introduction/Market Overview The US Market Analysis Dynamics Competitive Landscape Company Profiles
The US Long Acting Analgesics Market: Coverage Scope of the Report Attributes Title Coverage Market Influencing Variables
Details The US Long Acting Analgesic Market: Size, Trends & Forecasts (2017-2021) The US Market Growth Drivers, Challenges, Market Trends
Forecast Period of Market
2017-2021
Competition in the Market
Many companies are currently in development phase, so the companies in long acting analgesics currently face competition with companies in short acting analgesic market.
Key Players
Heron Therapeutics Inc., Pacira Pharmaceutical Inc., Fresenius Group
The US Long Acting Analgesic Market Executive Summary Analgesics (also known as painkillers) are the drugs that are used with the purpose of getting relief from acute and chronic pain. The pain relief in the case of analgesics takes place without loss of consciousness, in contrast to an anesthetic, which is a substance that imparts insensitivity to pain with the help of unconsciousness and elimination of sensory awareness. The US analgesic market can be divided on the basis of type, mode of administration and duration. On the basis of type, the market can be sub segmented into opioid and non opioid. On the basis of mode of administration, the market can be divided into intravenous and locally delivered analgesics. On the basis of duration, the market can be further segmented into long acting and short acting analgesics. The US long acting analgesic market is expected to increase at high growth rates during the forecast period (2017-2021). The US long acting analgesic market is supported by various growth factors such as increasing elderly population,, increase in use of non opioid analgesics especially in orthopedic procedures and disadvantages of opioids. However, issues faced by PCRX in the commercialization of EXPAREL is major challenge faced by the market. Upsurge in research and development expenses, low penetration of currently used local analgesics, evolution of multimodal analgesics and long acting analgesics in pipeline are some of the latest trends existing in the market.
The US Long Acting Analgesic Market Market Overview
Post Post Operative Operative Pain Pain Market Market Analgesic Analgesic Market Market Long Long Acting Acting Analgesic Analgesic Market Market
The US Analgesic Market: An Analysis
Million
The US Analgesic Market by Number of Procedures
2016
2017
2018
2019
2020
2021
A total of … million surgical procedures occurred in the US in 2016. It is estimated that … million surgical procedures would happen in the US by 2021 in comparison to …million surgical procedures in 2017.
The US Analgesic Market: Segment Analysis The US Analgesic Market Procedures by Segments; 2016
8%
Segments
Share
Soft Tissue Procedures
xx%
Orthopedic Procedures
xx%
Nerve Block Procedures
xx%
15%
76%
The US Analgesic Market: Segment Analysis The US Analgesic Market by Number of Nerve Block Procedures
Million
Million
The US Analgesic Market by Number of Orthopedic Procedures
2016
2017
2018
2019
2020
2021
The US Analgesic Market by Number of Soft Tissue Procedures
2016
2017
Segments
78
2019
CAGR 2016-2021
77 76 Million
2018
75
Orthopedic Procedures
..%
74
Soft Tissue Procedures
..%
73
Nerve Block Procedures
..%
72 2016
2017
2018
2019
2020
2021
2020
2021
The US Long Acting Analgesic Market: Penetration Analysis The US Long Acting Analgesic Market by Penetration
The US Long Acting Market by HTX-011 Penetration
Percentage , %
Percentage, %
5% 4% 3% 2% 1%
0.01
0% 2019 2016
2017
2018
2019
2020
2021
Percentage, %
2017
2018
Orthopedic Procedures
2019
2020
Soft Tissue Procedures
Orthopedic Procedures
2021 Soft Tissue Procedures
Nerve Block Procedures
The US Long Acting Analgesic Market by EXPAREL Penetration
2016
2020
2021
Name of Long Acting Analgesic
Penetration (Percentage,%)
EXPAREL
xx%
HTX-011
xx%
The US Long Acting Analgesic Market: Dynamics
Growth Driver • Increasing Aging Population • Disadvantages of Opioids
Challenges • Challenges in Commercialization of Exparel
Market Trends • Low Penetration of Currently Used Local Analgesics • Long Acting Analgesics in Pipeline
The US Long Acting Analgesic Market: Competitive Landscape Players Profiled • Heron Therapeutics Inc. • Pacira Pharmaceutical Inc.
• Fresenius Group
(Short Acting Analgesic – Indirect Competition)
Note: The graphs on this slide are only for sample representation.
Title: The US Long Acting Analgesic Market: Size, Trends & Forecasts (2017-2021) Published: Nov 2017 Pages: 51 Price: US$ 800 (Single-User License) : US$ 1400 (Corporate License) For more Info: http://www.daedal-research.com// the-us-long-acting-analgesic-market-size-trends-forecasts-2017-2021 For more details please contact Mr. Rajeev Kumar: Tel: +91-120-4553017 (9.30 am - 6.30 pm) IST Mobile: +91- 9811715635 (24 X7) Enquiries: info@daedal-research.com
Daedal Research
Daedal Research is a research and consulting firm specialized in providing research reports and customized business research and analysis. The research firm offers a blend of the best strategic consulting and market research solutions, which promise data rich, cost effective, and highly insightful analysis to help its clients with perfect answers to their important business queries.